These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 30978603)

  • 1. Furofuran lignans as a new series of antidiabetic agents exerting α-glucosidase inhibition and radical scarvenging: Semisynthesis, kinetic study and molecular modeling.
    Worawalai W; Doungwichitrkul T; Rangubpit W; Taweechat P; Sompornpisut P; Phuwapraisirisan P
    Bioorg Chem; 2019 Jun; 87():783-793. PubMed ID: 30978603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of furofuran lignans as antidiabetic agents simultaneously achieved by inhibiting α-glucosidase and free radical.
    Worawalai W; Khongchai P; Surachaitanawat N; Phuwapraisirisan P
    Arch Pharm Res; 2016 Oct; 39(10):1370-1381. PubMed ID: 27338734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of 3-styrylchromone derivatives as free radical scavengers and α-glucosidase inhibitors.
    Takao K; Ishikawa R; Sugita Y
    Chem Pharm Bull (Tokyo); 2014; 62(8):810-5. PubMed ID: 25087634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and in vitro evaluation of chlorogenic acid amides as potential hypoglycemic agents and their synergistic effect with acarbose.
    Cardullo N; Floresta G; Rescifina A; Muccilli V; Tringali C
    Bioorg Chem; 2021 Dec; 117():105458. PubMed ID: 34736132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and Biological Evaluation of 3-Benzylidene-4-chromanone Derivatives as Free Radical Scavengers and α-Glucosidase Inhibitors.
    Takao K; Yamashita M; Yashiro A; Sugita Y
    Chem Pharm Bull (Tokyo); 2016; 64(8):1203-7. PubMed ID: 27477661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quercitylcinnamates, a new series of antidiabetic bioconjugates possessing α-glucosidase inhibition and antioxidant.
    Rattanangkool E; Kittikhunnatham P; Damsud T; Wacharasindhu S; Phuwapraisirisan P
    Eur J Med Chem; 2013 Aug; 66():296-304. PubMed ID: 23811091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A trisaccharide phenylethanoid glycoside from Scrophularia flava Grau with potential anti-type 2 diabetic properties by inhibiting α-glucosidase enzyme and decreasing oxidative stress.
    Hamedi A; Pasdaran A; Pasdaran A
    Bioorg Chem; 2020 Jun; 99():103776. PubMed ID: 32276136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Samin-derived flavonolignans, a new series of antidiabetic agents having dual inhibition against α-glucosidase and free radicals.
    Worawalai W; Phuwapraisirisan P
    Nat Prod Res; 2020 Nov; 34(22):3169-3175. PubMed ID: 30618297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New arylalkanones from Horsfieldia macrobotrys, effective antidiabetic agents concomitantly inhibiting α-glucosidase and free radicals.
    Ramadhan R; Phuwapraisirisan P
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4529-33. PubMed ID: 26343830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thioether and Ether Furofuran Lignans: Semisynthesis, Reaction Mechanism, and Inhibitory Effect against α-Glucosidase and Free Radicals.
    Worawalai W; Surachaitanawat N; Khongchai P; Vchirawongkwin V; Aree T; Phuwapraisirisan P
    Molecules; 2022 Dec; 27(24):. PubMed ID: 36558136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and in vitro α-glucosidase inhibition of novel dihydropyrano[3,2-c]quinoline derivatives as potential anti-diabetic agents.
    Nikookar H; Mohammadi-Khanaposhtani M; Imanparast S; Faramarzi MA; Ranjbar PR; Mahdavi M; Larijani B
    Bioorg Chem; 2018 Apr; 77():280-286. PubMed ID: 29421703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biscoumarin-1,2,3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro α-glucosidase inhibition, kinetic, and docking studies.
    Asgari MS; Mohammadi-Khanaposhtani M; Kiani M; Ranjbar PR; Zabihi E; Pourbagher R; Rahimi R; Faramarzi MA; Biglar M; Larijani B; Mahdavi M; Hamedifar H; Hajimiri MH
    Bioorg Chem; 2019 Nov; 92():103206. PubMed ID: 31445191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel cinnamic acid magnolol derivatives as potent α-glucosidase and α-amylase inhibitors: Synthesis, in vitro and in silico studies.
    Hu CM; Wang WJ; Ye YN; Kang Y; Lin J; Wu PP; Li DL; Bai LP; Xu XT; Li BQ; Zhang K
    Bioorg Chem; 2021 Nov; 116():105291. PubMed ID: 34438122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of piperic acid amides as free radical scavengers and α-glucosidase inhibitors.
    Takao K; Miyashiro T; Sugita Y
    Chem Pharm Bull (Tokyo); 2015; 63(5):326-33. PubMed ID: 25948326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of highly potent α-glucosidase inhibitory and antioxidant constituents from Zizyphus rugosa bark: enzyme kinetic and molecular docking studies with active metabolites.
    Sichaem J; Aree T; Lugsanangarm K; Tip-Pyang S
    Pharm Biol; 2017 Dec; 55(1):1436-1441. PubMed ID: 28320255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New 6-amino-pyrido[2,3-d]pyrimidine-2,4-diones as novel agents to treat type 2 diabetes: A simple and efficient synthesis, α-glucosidase inhibition, molecular modeling and kinetic study.
    Adib M; Peytam F; Rahmanian-Jazi M; Mahernia S; Bijanzadeh HR; Jahani M; Mohammadi-Khanaposhtani M; Imanparast S; Faramarzi MA; Mahdavi M; Larijani B
    Eur J Med Chem; 2018 Jul; 155():353-363. PubMed ID: 29902721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new entry into the portfolio of α-glucosidase inhibitors as potent therapeutics for type 2 diabetes: Design, bioevaluation and one-pot multi-component synthesis of diamine-bridged coumarinyl oxadiazole conjugates.
    Kazmi M; Zaib S; Ibrar A; Amjad ST; Shafique Z; Mehsud S; Saeed A; Iqbal J; Khan I
    Bioorg Chem; 2018 Apr; 77():190-202. PubMed ID: 29421697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
    Riaz S; Khan IU; Bajda M; Ashraf M; Qurat-Ul-Ain ; Shaukat A; Rehman TU; Mutahir S; Hussain S; Mustafa G; Yar M
    Bioorg Chem; 2015 Dec; 63():64-71. PubMed ID: 26451651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study.
    Saeedi M; Mohammadi-Khanaposhtani M; Pourrabia P; Razzaghi N; Ghadimi R; Imanparast S; Faramarzi MA; Bandarian F; Esfahani EN; Safavi M; Rastegar H; Larijani B; Mahdavi M; Akbarzadeh T
    Bioorg Chem; 2019 Mar; 83():161-169. PubMed ID: 30366316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arylalkanones from Horsfieldia macrobotrys are effective antidiabetic agents achieved by α-glucosidase inhibition and radical scavenging.
    Ramadhan R; Phuwapraisirisan P
    Nat Prod Commun; 2015 Feb; 10(2):325-8. PubMed ID: 25920275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.